A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

NCT00454389 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

494

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Degeneration

Interventions

DEVICE: Epi-Rad90™ Ophthalmic System
DRUG: ranibizumab

Sponsor

NeoVista